Mutual Of America Capital Management LLC Avidity Biosciences, Inc. Transaction History
Mutual Of America Capital Management LLC
- $9.32 Billion
- Q3 2024
A detailed history of Mutual Of America Capital Management LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 164,997 shares of RNA stock, worth $6.81 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
164,997
Previous 184,249
10.45%
Holding current value
$6.81 Million
Previous $7.53 Million
0.69%
% of portfolio
0.08%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding RNA
# of Institutions
256Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$439 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$381 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$356 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$336 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$290 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.15B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...